Drugs / [11C]MPC6827
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04575727 | Jan 2021 → Jun 2024 | Alzheimer disease, amyotrophic lateral sclerosis | Columbia University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [11C]MPC6827 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04575727 ↗ |
| Modality | Diagnostic / imaging agent | “experimental imaging test” NCT04575727 ↗ |